These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 28745123)
1. iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery. Ma L; Chen Q; Ma P; Han MK; Xu Z; Kang Y; Xiao B; Merlin D Nanomedicine (Lond); 2017 Aug; 12(16):1991-2006. PubMed ID: 28745123 [TBL] [Abstract][Full Text] [Related]
2. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200 [TBL] [Abstract][Full Text] [Related]
3. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan. Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937 [TBL] [Abstract][Full Text] [Related]
4. Chondroitin sulfate-functionalized polymeric nanoparticles for colon cancer-targeted chemotherapy. Zu M; Ma L; Zhang X; Xie D; Kang Y; Xiao B Colloids Surf B Biointerfaces; 2019 May; 177():399-406. PubMed ID: 30785037 [TBL] [Abstract][Full Text] [Related]
5. Tumor-homing peptide iRGD-conjugate enhances tumor accumulation of camptothecin for colon cancer therapy. Singh T; Kim TW; Murthy ASN; Paul M; Sepay N; Jeong Kong H; Sung Ryu J; Rim Koo N; Yoon S; Song KH; Jun Baek M; Jeon S; Im J Eur J Med Chem; 2024 Feb; 265():116050. PubMed ID: 38128233 [TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy. Xiao B; Han MK; Viennois E; Wang L; Zhang M; Si X; Merlin D Nanoscale; 2015 Nov; 7(42):17745-55. PubMed ID: 26455329 [TBL] [Abstract][Full Text] [Related]
7. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability. Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942 [TBL] [Abstract][Full Text] [Related]
8. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548 [TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of tumour microenvironment response multistage nanoparticles for epirubicin delivery and deep tumour penetration. Dai J; Han S; Ju F; Han M; Xu L; Zhang R; Sun Y Artif Cells Nanomed Biotechnol; 2018; 46(sup2):860-873. PubMed ID: 29771149 [TBL] [Abstract][Full Text] [Related]
10. Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment. Zhong Y; Su T; Shi Q; Feng Y; Tao Z; Huang Q; Li L; Hu L; Li S; Tan H; Liu S; Yang H Int J Nanomedicine; 2019; 14():8543-8560. PubMed ID: 31802868 [TBL] [Abstract][Full Text] [Related]
11. iRGD-Guided Silica/Gold Nanoparticles for Efficient Tumor-Targeting and Enhancing Antitumor Efficacy Against Breast Cancer. Hou X; Chen Q; Fang Y; Zhang L; Huang S; Xu M; Ren Y; Shi Z; Wei Y; Li L Int J Nanomedicine; 2024; 19():8237-8251. PubMed ID: 39157735 [TBL] [Abstract][Full Text] [Related]
12. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles. Jang DJ; Moon C; Oh E Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053 [TBL] [Abstract][Full Text] [Related]
13. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery. Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060 [TBL] [Abstract][Full Text] [Related]
14. iRGD-mediated core-shell nanoparticles loading carmustine and O Liu C; Yao S; Li X; Wang F; Jiang Y J Drug Target; 2017 Mar; 25(3):235-246. PubMed ID: 27646474 [TBL] [Abstract][Full Text] [Related]
15. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22. Yang A; Liu Z; Yan B; Zhou M; Xiong X Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540 [TBL] [Abstract][Full Text] [Related]
16. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles. Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683 [TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells. Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284 [TBL] [Abstract][Full Text] [Related]
18. Enzyme sensitive, surface engineered nanoparticles for enhanced delivery of camptothecin. Yu H; Chen J; Liu S; Lu Q; He J; Zhou Z; Hu Y J Control Release; 2015 Oct; 216():111-20. PubMed ID: 26282096 [TBL] [Abstract][Full Text] [Related]
19. Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer. Zhao C; Cao W; Zheng H; Xiao Z; Hu J; Yang L; Chen M; Liang G; Zheng S; Zhao C Int J Nanomedicine; 2019; 14():1597-1618. PubMed ID: 30880968 [TBL] [Abstract][Full Text] [Related]
20. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound. Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]